349 related articles for article (PubMed ID: 34121995)
1. Therapeutic Potential of Selenium in Glioblastoma.
Yakubov E; Eibl T; Hammer A; Holtmannspötter M; Savaskan N; Steiner HH
Front Neurosci; 2021; 15():666679. PubMed ID: 34121995
[TBL] [Abstract][Full Text] [Related]
2. Metabolic and functional reprogramming of myeloid-derived suppressor cells and their therapeutic control in glioblastoma.
Won WJ; Deshane JS; Leavenworth JW; Oliva CR; Griguer CE
Cell Stress; 2019 Jan; 3(2):47-65. PubMed ID: 31225500
[TBL] [Abstract][Full Text] [Related]
3. Increased Expression of System xc- in Glioblastoma Confers an Altered Metabolic State and Temozolomide Resistance.
Polewski MD; Reveron-Thornton RF; Cherryholmes GA; Marinov GK; Cassady K; Aboody KS
Mol Cancer Res; 2016 Dec; 14(12):1229-1242. PubMed ID: 27658422
[TBL] [Abstract][Full Text] [Related]
4. Selenium Enhances the Apoptotic Efficacy of Docetaxel Through Activation of TRPM2 Channel in DBTRG Glioblastoma Cells.
Ertilav K; Nazıroğlu M; Ataizi ZS; Braidy N
Neurotox Res; 2019 May; 35(4):797-808. PubMed ID: 30796690
[TBL] [Abstract][Full Text] [Related]
5. FTY720 Exerts Anti-Glioma Effects by Regulating the Glioma Microenvironment Through Increased CXCR4 Internalization by Glioma-Associated Microglia.
Guo XD; Ji J; Xue TF; Sun YQ; Guo RB; Cheng H; Sun XL
Front Immunol; 2020; 11():178. PubMed ID: 32194542
[No Abstract] [Full Text] [Related]
6. Targeting CXCR4 by a selective peptide antagonist modulates tumor microenvironment and microglia reactivity in a human glioblastoma model.
Mercurio L; Ajmone-Cat MA; Cecchetti S; Ricci A; Bozzuto G; Molinari A; Manni I; Pollo B; Scala S; Carpinelli G; Minghetti L
J Exp Clin Cancer Res; 2016 Mar; 35():55. PubMed ID: 27015814
[TBL] [Abstract][Full Text] [Related]
7. Glioblastoma cells induce differential glutamatergic gene expressions in human tumor-associated microglia/macrophages and monocyte-derived macrophages.
Choi J; Stradmann-Bellinghausen B; Yakubov E; Savaskan NE; Régnier-Vigouroux A
Cancer Biol Ther; 2015; 16(8):1205-13. PubMed ID: 26047211
[TBL] [Abstract][Full Text] [Related]
8. Rethinking mercury: the role of selenium in the pathophysiology of mercury toxicity.
Spiller HA
Clin Toxicol (Phila); 2018 May; 56(5):313-326. PubMed ID: 29124976
[TBL] [Abstract][Full Text] [Related]
9. Selenium action in neuro-oncology.
Yakubov E; Buchfelder M; Eyüpoglu IY; Savaskan NE
Biol Trace Elem Res; 2014 Dec; 161(3):246-54. PubMed ID: 25164034
[TBL] [Abstract][Full Text] [Related]
10. SLC7A11 Overexpression in Glioblastoma Is Associated with Increased Cancer Stem Cell-Like Properties.
Polewski MD; Reveron-Thornton RF; Cherryholmes GA; Marinov GK; Aboody KS
Stem Cells Dev; 2017 Sep; 26(17):1236-1246. PubMed ID: 28610554
[TBL] [Abstract][Full Text] [Related]
11. Myeloid Cells in Glioblastoma Microenvironment.
De Leo A; Ugolini A; Veglia F
Cells; 2020 Dec; 10(1):. PubMed ID: 33374253
[TBL] [Abstract][Full Text] [Related]
12. Biological activity of selenium: Revisited.
Wrobel JK; Power R; Toborek M
IUBMB Life; 2016 Feb; 68(2):97-105. PubMed ID: 26714931
[TBL] [Abstract][Full Text] [Related]
13. Role of myeloid cells in the immunosuppressive microenvironment in gliomas.
Locarno CV; Simonelli M; Carenza C; Capucetti A; Stanzani E; Lorenzi E; Persico P; Della Bella S; Passoni L; Mavilio D; Bonecchi R; Locati M; Savino B
Immunobiology; 2020 Jan; 225(1):151853. PubMed ID: 31703822
[TBL] [Abstract][Full Text] [Related]
14. Interplay between Selenium, Selenoproteins and HIV-1 Replication in Human CD4 T-Lymphocytes.
Guillin OM; Vindry C; Ohlmann T; Chavatte L
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163318
[TBL] [Abstract][Full Text] [Related]
15. Is selenium a potential treatment for cancer metastasis?
Chen YC; Prabhu KS; Mastro AM
Nutrients; 2013 Apr; 5(4):1149-68. PubMed ID: 23567478
[TBL] [Abstract][Full Text] [Related]
16. Perspectives on Microglia-Based Immune Therapies Against Glioblastoma.
Rivera M; Bander ED; Cisse B
World Neurosurg; 2021 Oct; 154():228-231. PubMed ID: 34583500
[TBL] [Abstract][Full Text] [Related]
17.
Li Y; Guo S; Zhao K; Conrad C; Driescher C; Rothbart V; Schlomann U; Guerreiro H; Bopp MH; König A; Carl B; Pagenstecher A; Nimsky C; Bartsch JW
Biol Chem; 2021 Jan; 402(2):195-206. PubMed ID: 33544472
[TBL] [Abstract][Full Text] [Related]
18. Tumor microenvironment tenascin-C promotes glioblastoma invasion and negatively regulates tumor proliferation.
Xia S; Lal B; Tung B; Wang S; Goodwin CR; Laterra J
Neuro Oncol; 2016 Apr; 18(4):507-17. PubMed ID: 26320116
[TBL] [Abstract][Full Text] [Related]
19. Selenium-dependent metabolic reprogramming during inflammation and resolution.
Korwar AM; Hossain A; Lee TJ; Shay AE; Basrur V; Conlon K; Smith PB; Carlson BA; Salis HM; Patterson AD; Prabhu KS
J Biol Chem; 2021; 296():100410. PubMed ID: 33581115
[TBL] [Abstract][Full Text] [Related]
20. Deletion of the RNA regulator HuR in tumor-associated microglia and macrophages stimulates anti-tumor immunity and attenuates glioma growth.
Wang J; Leavenworth JW; Hjelmeland AB; Smith R; Patel N; Borg B; Si Y; King PH
Glia; 2019 Dec; 67(12):2424-2439. PubMed ID: 31400163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
